TraKine™线粒体染色试剂盒（橘红色荧光）

产品概述

专为哺乳动物细胞线粒体标记设计的高效染色解决方案，适用于活细胞/固定细胞、悬浮/贴壁细胞双模式实验场景。兼容荧光微孔板分析、流式细胞仪及荧光显微镜等平台，满足多维度研究需求。

核心组分

• 线粒体染料 MitoOrange™ (1000×)
• 实验缓冲液 (10×)

技术优势

• 广谱适用性：经优化的染料配方支持神经元、HeLa、HEK293等20+哺乳动物细胞系染色
• 专利荧光染料：MitoOrange™（Ex/Em = 579/599 nm）具备优异细胞膜穿透性，兼容甲醛固定后保留率达>95%
• 多平台验证：流式检测信号CV值<5%，显微镜成像信噪比>15:1

操作与保存

建议参照说明书进行梯度浓度测试，推荐工作浓度为1×-5×。各组分保存条件详见产品手册，未开封试剂-20℃避光保存有效期≥6个月。

物流信息

运输方式：专业冷链运输（蓝冰控温2-8℃）

现货库存：
• 100 T 规格 ¥406（次日发货）
• 500 T 规格 ¥1216（次日发货）

研究声明

警告：本产品限用于科研领域，不适用于临床诊断、治疗或任何人类应用。使用者应自行确认实验方案不侵犯第三方知识产权。

Product Overview

A high-efficiency staining solution specifically designed for mitochondrial labeling in mammalian cells, suitable for dual-mode experimental scenarios with live/fixed cells, suspension/adherent cells. Compatible with fluorescence microplate analysis, flow cytometry, and fluorescence microscopy platforms, meeting multidimensional research needs.

Core Components

• Mitochondrial Dye MitoOrange™ (1000×)
• Assay Buffer (10×)

Technical Advantages

• Broad Spectrum Applicability: Optimized dye formulation supports staining in 20+ mammalian cell lines including neurons, HeLa, and HEK293.
• Proprietary Fluorescent Dye: MitoOrange™ (Ex/Em = 579/599 nm) exhibits excellent cell membrane permeability and >95% retention rate post-formaldehyde fixation.
• Multi-Platform Validation: Flow cytometry signal CV <5%, microscopy imaging signal-to-noise ratio >15:1.

Operation & Storage

Gradient concentration testing is recommended as per the manual, with a suggested working concentration of 1×-5×. Storage conditions for each component are detailed in the product manual. Unopened reagents should be stored protected from light at -20℃ with a shelf life of ≥6 months.

Logistics Information

Shipping Method: Professional cold chain transport (2-8℃ controlled with blue ice)

In-Stock Inventory:
• 100 T Specification ¥406 (Next-day delivery)
• 500 T Specification ¥1216 (Next-day delivery)

Research Statement

Warning: This product is limited to research use only, not for clinical diagnosis, treatment, or any human applications. Users must independently confirm that experimental protocols do not infringe upon third-party intellectual property rights.